Rongfu Wang Selected Research

Malaria

11/2020	RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology.
10/2016	Increased CD40 Expression Enhances Early STING-Mediated Type I Interferon Response and Host Survival in a Rodent Malaria Model.
1/2014	Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rongfu Wang Research Topics

Disease

28	Neoplasms (Cancer) 01/2023 - 07/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2018
4	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2018
4	Lymphoma (Lymphomas) 01/2022 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2022
3	Testicular Neoplasms (Testicular Cancer) 01/2022 - 12/2018
3	Malaria 11/2020 - 01/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2016
3	Cognitive Dysfunction 01/2019 - 01/2016
3	Infections 10/2018 - 01/2014
2	Glioma (Gliomas) 01/2023 - 01/2023
2	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2021
2	Disease Progression 01/2022 - 10/2020
2	Carcinoma (Carcinomatosis) 12/2021 - 01/2018
2	Adenocarcinoma of Lung 11/2020 - 12/2018
2	Virus Diseases (Viral Diseases) 11/2020 - 01/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2020 - 01/2013
2	Multiple Myeloma 06/2020 - 01/2018
2	Liver Neoplasms (Liver Cancer) 01/2018 - 02/2013
2	Hepatocellular Carcinoma (Hepatoma) 02/2013 - 09/2005
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Lymphatic Metastasis 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Progeria (Hutchinson Gilford Syndrome) 11/2021
1	Brain Injuries (Brain Injury) 10/2021
1	Ischemia 10/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	Necrosis 11/2020
1	Thrombosis (Thrombus) 10/2020
1	Anemia 12/2018
1	Fever (Fevers) 12/2018

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2005
6	AntigensIBA 01/2023 - 07/2002
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
4	Monoclonal AntibodiesIBA 01/2023 - 01/2018
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2018
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 10/2020
4	Peptides (Polypeptides)IBA 04/2022 - 01/2019
4	LigandsIBA 04/2022 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2014
3	daratumumabIBA 01/2022 - 01/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 12/2018
3	Arginine (L-Arginine)FDA Link 10/2021 - 02/2017
3	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2014
3	MicroRNAs (MicroRNA)IBA 02/2016 - 02/2013
2	Small Interfering RNA (siRNA)IBA 01/2023 - 02/2017
2	Messenger RNA (mRNA)IBA 11/2021 - 11/2014
2	Leucine (L-Leucine)FDA Link 10/2021 - 01/2019
2	Apolipoproteins E (ApoE)IBA 01/2019 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2016
1	Radioisotopes (Radionuclides)IBA 01/2023
1	Cytosine DeaminaseIBA 01/2023
1	Zinc Finger E-box-Binding Homeobox 1IBA 01/2023
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2022
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 04/2022
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2021
1	Sirtuin 1IBA 11/2021
1	VER 155008IBA 10/2021
1	arginyl-arginyl-leucineIBA 10/2021
1	Biotin (Vitamin H)FDA Link 10/2021
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2021
1	3-methylquercetinIBA 10/2021
1	obinutuzumabIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	EnzymesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 11/2020
1	squamous cell carcinoma-related antigenIBA 11/2020
1	pro-gastrin-releasing peptide (31-98)IBA 11/2020
1	CarbohydratesIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Tumor Biomarkers (Tumor Markers)IBA 11/2020
1	Gastrin-Releasing PeptideIBA 11/2020
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 11/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2020
1	Integrin alpha4beta1 (VLA-4)IBA 06/2020
1	CytokinesIBA 06/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	ApolipoproteinsIBA 01/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2019
1	florbetapirIBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018
1	InterferonsIBA 10/2018

Therapy/Procedure

12	Therapeutics 01/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
3	Immunotherapy 01/2022 - 07/2002
2	Radioimmunotherapy 01/2023 - 01/2021
2	Precision Medicine 01/2021 - 01/2018
1	Rejuvenation 11/2021
1	Radiotherapy 01/2021
1	Nephrectomy 10/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2018